載入...
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780
Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid Aβ1-42, in the brain. Aβ1-42 levels can be decreased by γ-secretase modulators (GSM), which are small molecules that modulate γ-secretase, an...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Hindawi Publishing Corporation
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4109680/ https://ncbi.nlm.nih.gov/pubmed/25097793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/431858 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|